trihexyphenidyl has been researched along with Brain Damage, Chronic in 2 studies
Trihexyphenidyl: One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic.
Brain Damage, Chronic: A condition characterized by long-standing brain dysfunction or damage, usually of three months duration or longer. Potential etiologies include BRAIN INFARCTION; certain NEURODEGENERATIVE DISORDERS; CRANIOCEREBRAL TRAUMA; ANOXIA, BRAIN; ENCEPHALITIS; certain NEUROTOXICITY SYNDROMES; metabolic disorders (see BRAIN DISEASES, METABOLIC); and other conditions.
Excerpt | Relevance | Reference |
---|---|---|
"In older patients hemidystonia appeared within 6 months after injury." | 1.27 | Hemidystonia: a report of 22 patients and a review of the literature. ( Jankovic, J; Pettigrew, LC, 1985) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Pettigrew, LC | 1 |
Jankovic, J | 1 |
Hader, M | 1 |
2 other studies available for trihexyphenidyl and Brain Damage, Chronic
Article | Year |
---|---|
Hemidystonia: a report of 22 patients and a review of the literature.
Topics: Adolescent; Adult; Aged; Basal Ganglia Diseases; Brain Damage, Chronic; Brain Diseases; Brain Injuri | 1985 |
Antiparkinsonism medication for the phenothiazine-induced pyramidal-extrapyramidal syndrome in elderly brain-damaged patients.
Topics: Aged; Brain Damage, Chronic; Chlorpromazine; Female; Humans; Male; Parkinson Disease; Perphenazine; | 1965 |